Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Rita Suhadi"'
Publikováno v:
Pharmaciana, Vol 11, Iss 1, Pp 49-60 (2021)
The clinical guideline recommends home monitoring for hypertension, diabetes, and hyperlipidemia maintenance therapy. The study aimed to compare the 10-year atherosclerotic cardiovascular disease (ASCVD) risk calculated using systolic blood pressure,
Externí odkaz:
https://doaj.org/article/239288b59c654db79ad0313357e4a618
Autor:
Gregorius Bhaskara Wikanendra, Rita Suhadi, Christianus Heru Setiawan, Dita Maria Virginia, Phebe Hendra, Fenty Fenty
Publikováno v:
Jurnal Farmasi Sains dan Komunitas, Vol 17, Iss 2, Pp 86-91 (2020)
Sleep deprivation is a risk factor for cardiovascular and metabolic diseases. There was a high prevalence of high blood pressure and type 2 diabetes in Morangan, Yogyakarta Province. This study aims at studying the correlation between sleep duration,
Externí odkaz:
https://doaj.org/article/a7f4742a35b34c8c94fe6292cb3bf21e
Autor:
Christianus Heru Setiawan, Rita Suhadi, Phebe Hendra, Fenty Fenty, Dita Maria Virginia, Gregorius Bhaskara Wikanendra
Publikováno v:
Jurnal Farmasi Sains dan Komunitas, Vol 17, Iss 2, Pp 112-119 (2020)
Cardiovascular disease is the highest cause of mortality in Indonesia. One of the factors that causes the disease is low level of health awareness, including healthy lifestyle and health control. Improving public health awareness can be done by provi
Externí odkaz:
https://doaj.org/article/edd1f5af1e304451a74fb1d7bb8b6d8d
THE EFFECT OF HEALTH INSURANCE ON ASTHMA CONTROL IN RESPONDENTS WITH ASTHMA IN YOGYAKARTA, INDONESIA
Publikováno v:
Jurnal Farmasi Sains dan Komunitas, Vol 15, Iss 2, Pp 62-67 (2018)
Asthma is a chronic disease with recurrent breath shortness. Until now, there is no particular therapy to cure the disease and long-term treatment is needed to control the disease. Health insurance has the benefit to support the asthma therapy. This
Externí odkaz:
https://doaj.org/article/ad11598dfa774b8b92074e0c3a5df619
Publikováno v:
Jurnal Manajemen dan Pelayanan Farmasi, Vol 8, Iss 2, Pp 59-69 (2018)
Cardiovascular disease is the highest cause of death with total of 17.5 million deaths in the world. Nowadays there have beenexists many methods to calculate the risk of cardiovascular disease within the next 10 years, 5 of them are Framingham Risk S
Externí odkaz:
https://doaj.org/article/2481ae84fa0d4ebfa1ab541add6c27ea
Publikováno v:
Jurnal Farmasi Sains dan Komunitas, Vol 14, Iss 2, Pp 93-103 (2017)
Hypertension is systolic blood pressure (SBP) ≥140mmHg and/or diastolic blood pessure (DBP) ≥90mmHg. The risk factors of hypertension consist of age, life-style, demographic, and social factors. The risk factors have a significant association wit
Externí odkaz:
https://doaj.org/article/cf5171e7e7aa4b558f651e28bb3e2a20
Publikováno v:
Journal of Primary Care & Community Health, Vol 9 (2018)
Background: Evidence from previous studies demonstrates that lifestyle modification reduces the incidence and complications of atherosclerotic cardiovascular disease. The study aimed to investigate the effect of a lifestyle intervention provided by p
Externí odkaz:
https://doaj.org/article/32bedf56bf2c4c95ae543645b1f7c4c5
Publikováno v:
Indonesian Journal of Pharmacy, Vol 25, Iss 2, Pp 111-118 (2014)
The study aimed to assess the effect of the blood pressure (BP) feedback intervention to physicians on the improvement of the blood pressure control of hypertension subjects. The study was done with controlled repeated intervention design. The adu
Externí odkaz:
https://doaj.org/article/845175b3caff49cf958df94f18d0cfc8
Publikováno v:
Pharmaciana, Vol 11, Iss 1, Pp 49-60 (2021)
The clinical guideline recommends home monitoring for hypertension, diabetes, and hyperlipidemia maintenance therapy. The study aimed to compare the 10-year atherosclerotic cardiovascular disease (ASCVD) risk calculated using systolic blood pressure,
Publikováno v:
Jurnal Farmasi Sains dan Komunitas, Vol 10, Iss 1 (2016)
Abstract: Background: Therapy intensification (TI) is the most important factor in blood pressure control among the adherent patients. The TI is the physician prescription behavior to add the item(s) and/or the dosage of hypertensive medicine when th
Externí odkaz:
https://doaj.org/article/9f833f80f6624118a1c777391ff02e44